Organon & Co. OGN
Set alert
At close · Oct 30
After hours · Oct 30, 4:42 PM ET
- YTD
- +93.03%
- 1 year
- +110.65%
- Open
- 13.83
- Prev close
- 13.81
- Mkt cap
- 3.63B
- Vol
- 1.85M
- Avg vol
- 2.59M
- EPS
- 0.78
- P/E
- 17.74
- Div yield
- 0.58%
More statistics
- Low
- 13.81
- High
- 13.84
- Forward P/E
- 3.79
- Beta
- 1.54
- Short ratio
- 8.54
- Inst. own
- 84.60%
- Dividend
- 0.08
- Ex-div date
- Aug 13, 2026
- Earnings
- Feb 11, 2027
- 50-d avg
- 13.74
- 200-d avg
- 11.49
- 1y target
- 10.33
5D chart
Events in this range
- Oct 30, 2026Earnings: 0.94; estimate 0.88; surprise 6.82%
Signals (57)
| Name | Time | Ago |
|---|---|---|
| RSI: Overbought | Oct 30, 3:55 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 3:30 PM | 2 days ago |
| RSI: Overbought | Oct 30, 3:30 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 2:00 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 1:40 PM | 2 days ago |
| RSI: Overbought | Oct 30, 1:40 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 12:25 PM | 2 days ago |
| MACD: Buy Signal | Oct 30, 12:10 PM | 2 days ago |
| RSI: Overbought | Oct 30, 12:10 PM | 2 days ago |
| MACD: Sell Signal | Oct 30, 10:20 AM | 2 days ago |
| RSI: Overbought | Oct 29, 3:55 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 3:30 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 3:05 PM | 3 days ago |
| MACD: Buy Signal | Oct 29, 2:45 PM | 3 days ago |
| RSI: Oversold | Oct 29, 2:25 PM | 3 days ago |
| MACD: Sell Signal | Oct 29, 11:50 AM | 3 days ago |
| RSI: Overbought | Oct 29, 10:45 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 10:35 AM | 3 days ago |
| MACD: Sell Signal | Oct 29, 9:55 AM | 3 days ago |
| MACD: Buy Signal | Oct 29, 9:50 AM | 3 days ago |
| MACD: Sell Signal | Oct 28, 3:45 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 3:40 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 3:35 PM | 4 days ago |
| RSI: Overbought | Oct 28, 2:55 PM | 4 days ago |
| MACD: Buy Signal | Oct 28, 2:00 PM | 4 days ago |
| RSI: Overbought | Oct 28, 2:00 PM | 4 days ago |
| MACD: Sell Signal | Oct 28, 11:25 AM | 4 days ago |
| MACD: Buy Signal | Oct 28, 11:15 AM | 4 days ago |
| MACD: Sell Signal | Oct 28, 10:55 AM | 4 days ago |
| SMA: Bullish | Oct 28, 9:30 AM | 4 days ago |
| MACD: Buy Signal | Oct 27, 3:25 PM | 5 days ago |
| MACD: Sell Signal | Oct 27, 11:25 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| SMA: Bullish | Oct 27, 9:50 AM | 5 days ago |
| MACD: Buy Signal | Oct 27, 9:50 AM | 5 days ago |
| MACD: Sell Signal | Oct 27, 9:35 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| SMA: Bearish | Oct 27, 9:30 AM | 5 days ago |
| MACD: Buy Signal | Oct 26, 3:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:10 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 3:05 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 3:00 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:45 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:40 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:35 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 2:25 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 2:05 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:50 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:40 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:35 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:30 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:15 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:10 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 1:05 PM | 6 days ago |
| MACD: Buy Signal | Oct 26, 1:00 PM | 6 days ago |
| MACD: Sell Signal | Oct 26, 12:40 PM | 6 days ago |
| RSI: Overbought | Oct 26, 11:45 AM | 6 days ago |
News
2 days ago zacks.com
Organon (OGN) Q3 Earnings and Revenues Top Estimates
Organon (OGN) came out with quarterly earnings of $0.94 per share, beating the Zacks Consensus Estimate of $0.91 per share. This compares to earnings of $1.01 per share a year ago.
2 days ago businesswire.com
Organon Announces Quarterly Dividend
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon Announces Quarterly Dividend.
6 days ago zacks.com
Organon & Co. (OGN) Is a Trending Stock: Facts to Know Before Betting on It
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
1 week ago businesswire.com
Organon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filing
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, plans to release its third…
2 weeks ago defenseworld.net
Organon & Co. (NYSE:OGN) & Xeris Biopharma (NASDAQ:XERS) Critical Comparison
Organon and Co. (NYSE: OGN - Get Free Report) and Xeris Biopharma (NASDAQ: XERS - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two businesses…
-
2 weeks ago benzinga.com
Organon To Present Data From Its Current Phase 3 Trial Of MIUDELLA Intrauterine Device At 2026 Society Of Family Planning Annual Meeting
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that Sebela Women’s Health will present interim…
2 weeks ago businesswire.com
Organon Announces Positive Interim Phase 3 Study Results for MIUDELLA®, a Hormone-Free, Intrauterine Device (IUD), Through 6 Years of Use to Be Presented at the 2026 Society of Family Planning Annual Meeting
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon reports positive interim Phase 3 results for MIUDELLA®, a hormone-free IUD, through 6 years of use with no new safety signals.
2 weeks ago zacks.com
Investors Heavily Search Organon & Co. (OGN): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Organon (OGN). This makes it worthwhile to examine what the stock has in store.
2 weeks ago accessnewswire.com
Orogen Royalties Enters into Agreement to Sell the Slaughterhouse Copper-Gold Project to Seabridge Gold
VANCOUVER, BC / ACCESS Newswire / October 13, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that it has signed a purchase and sale agreement…
3 weeks ago accessnewswire.com
Orogen Royalties Creates a Royalty on the Cibola Copper-Gold Project in British Columbia
VANCOUVER, BC / ACCESS Newswire / October 8, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce that it has signed a purchase and sale agreement…
1 month ago zacks.com
Here is What to Know Beyond Why Organon & Co. (OGN) is a Trending Stock
Organon (OGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
1 month ago businesswire.com
Organon to Present New Real-World Analysis of VTAMA® (tapinarof) Cream, 1%, at the 2026 Fall Clinical Dermatology Conference
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon to unveil first large-scale real-world effectiveness analyses of VTAMA (tapinarof) cream, 1% in patients with eczema at Fall Clinical.
-
1 month ago benzinga.com
Organon Canada Announces Availability Of NDUVRA To Treat Moderate To Severe Atopic Dermatitis
Organon Canada, a global healthcare company, today announces the approval and availability of NDUVRA® (tapinarof cream), 1%, for the topical treatment of moderate to severe atopic dermatitis in adult…
1 month ago zacks.com
Is Trending Stock Organon & Co. (OGN) a Buy Now?
Organon (OGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
1 month ago defenseworld.net
VIRGINIA RETIREMENT SYSTEMS ET Al Makes New $770,000 Investment in Organon & Co. $OGN
VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in shares of Organon and Co. (NYSE: OGN) in the second quarter, according to its most recent disclosure with the SEC. The firm purchased 56,850…
1 month ago businesswire.com
Organon Announces US FDA Has Accepted for Review a Supplemental New Drug Application for MIUDELLA®, a Hormone-Free Intrauterine Device
JERSEY CITY, N.J.--(BUSINESS WIRE)--Organon announces FDA accepts MIUDELLA® sNDA for review, seeking to extend approved hormone-free IUD use from 3 to 6 years in the U.S.
1 month ago accessnewswire.com
Orogen Royalties Acquires the Serpent Gold Project in Nevada
VANCOUVER, BC / ACCESS Newswire / September 10, 2026 / (TSXV:OGN)(OTCQX:OGNNF) Orogen Royalties Inc. ("Orogen" or the "Company") is pleased to announce the acquisition of the Serpent gold project in…
1 month ago zacks.com
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know
Zacks.com users have recently been watching Organon (OGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
2 months ago accessnewswire.com
Orogen Royalties Acquires Two Gold Projects in Southwest Utah
VANCOUVER, BC / ACCESS Newswire / September 2, 2026 / Orogen Royalties Inc. ("Orogen" or the "Company") (TSXV:OGN)(OTCQX:OGNNF) is pleased to announce the acquisition of the Toro de Oro and El…
2 months ago defenseworld.net
Bank of America Corp DE Has $4.42 Million Stock Position in Organon & Co. $OGN
Bank of America Corp DE reduced its position in shares of Organon and Co. (NYSE: OGN) by 58.5% in the undefined quarter, according to its most recent filing with the Securities and Exchange…
2 months ago globenewswire.com
National Can-RISE Study to Help Close Critical Gaps in Menopause Research
TORONTO, Aug. 27, 2026 (GLOBE NEWSWIRE) -- Women's Health Collective Canada (WHCC) and the Partnership for Women's Health Research Canada (PWHR), in partnership with GreenShield and supported by a…
2 months ago defenseworld.net
Organon & Co. (NYSE:OGN) Sets New 52-Week High – Still a Buy?
Organon and Co. (NYSE: OGN - Get Free Report) reached a new 52-week high during trading on Tuesday. The stock traded as high as $13.76 and last traded at $13.7540, with a volume of 4583387 shares…
2 months ago benzinga.com
This House of Representative Just Sold Up To $30K In Organon Stock
A report on August 12, 2026 shows that Representative Kevin Hern from Oklahoma sale stock in Organon (NYSE:OGN), valued between $2,002 and $30,000. According to the August filing, the transaction…
-
3 months ago benzinga.com
Organon To Present Results From Post Hoc Analysis Of Pooled Data From Phase 3 Pivotal Trials, ADORING 1 And ADORING 2, Evaluating VTAMA Cream Versus Vehicle At 2026 SPD Annual Meeting
The presentation at the 2026 Society for Pediatric Dermatology (SPD) Annual Meeting marked the first time pooled Phase 3 data from the ADORING 1 and 2 trials on Validated Investigator Global…
-
3 months ago benzinga.com
Organon To Present Phase 3 Data Of VTAMA Cream In Atopic Dermatitis At 2026 Society For Pediatric Dermatology Annual Meeting
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced that a new analysis of Phase 3 data evaluating…
-
4 months ago benzinga.com
Organon And Samsung Bioepis Expand Their Development And Commercialization Agreement To Provide OGN With Commercialization Rights In Canada To PYZCHIVA, Samsung Bioepis's Biosimilar Referencing STELARA
PYZCHIVA® is indicated for the treatment of adult patients with chronic moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy, active psoriatic arthritis,…
-
4 months ago benzinga.com
Organon's Supplemental Biologics License Application Gets FDA Approval For TOFIDENCE To Treat Chimeric Antigen Receptor T Cell-Induced Severe Or Life-Threatening Cytokine Release Syndrome
Organon (NYSE:OGN) today announced the US Food and Drug Administration (FDA) approval of the supplemental Biologics License Application (sBLA) for TOFIDENCE® (tocilizumab-bavi) injection, for…
6 months ago benzinga.com
Deal Dispatch: Sirius XM Mulls Purchase Of iHeartMedia, Uber Buys FlyTaxi, Wren Kitchens Bankruptcy
Major M&A deals this week include: Eli Lilly buys Profluent for $2.2 billion, Lazard buys Campbell Lutyens, FreshRealm bankruptcy.
-
6 months ago benzinga.com
Organon Q1 Adj. EPS $0.71 Misses $0.83 Estimate, Sales $1.460B Miss $1.484B Estimate
Organon (NYSE:OGN) reported quarterly earnings of $0.71 per share which missed the analyst consensus estimate of $0.83 by 14.46 percent. This is a 30.39 percent decrease over earnings of $1.02 per…
6 months ago benzinga.com
Organon Stock's Momentum Score Jumps As $11.75 Billion Sun Pharma Takeover Deal Sparks Global Pharma Consolidation Push
Organon momentum score jumps as Sun Pharma's $11.75B all-cash acquisition deal boosts outlook, lifting stock trends across timeframes.
-
6 months ago benzinga.com
BNP Paribas Downgrades Organon to Neutral, Raises Price Target to $14
BNP Paribas analyst Navann Ty downgrades Organon (NYSE:OGN) from Outperform to Neutral and raises the price target from $12 to $14.
6 months ago benzinga.com
This Old Dominion Freight Line Analyst Is No Longer Bearish; Here Are Top 3 Upgrades For Tuesday
Analysts upgraded ODFL, TFII, OGN with positive outlook. See analyst ratings and stock performance.
-
6 months ago benzinga.com
Piper Sandler Upgrades Organon to Neutral, Raises Price Target to $14
Piper Sandler analyst David Amsellem upgrades Organon (NYSE:OGN) from Underweight to Neutral and raises the price target from $5 to $14.
6 months ago benzinga.com
Nasdaq 100 Eases From Records As Brent Tops $108: Stock Market Today
U.S. tech stocks eased from record highs as Brent surges 2.9% to $108 ahead of Big Tech earnings and the FOMC meeting this week.
6 months ago benzinga.com
XOMA Royalty, Oruka Therapeutics, Repay Holdings And Other Big Stocks Moving Higher On Monday
U.S. stocks were lower, Dow Jones fell 0.1% on Monday. XOMA shares rose on Ligand's plans to acquire XOMA for $39.00/share. Other big gainers: MANE, ORKA, OGN, XE, PLBL, SLS, ANAB, EVH, IHRT, RPAY,…
6 months ago benzinga.com
Stock Market Today: Dow Futures Fall, S&P 500 Gains As Trump Halts Iran Talks— Organon, SAP, Cheetah Net Supply Chain Service In Focus (UPDATED)
Editor’s Note: The future prices of benchmark tracking ETFs, the lede, the economic data and the headline were updated in the story. The S&P 500 and Nasdaq 100 futures pared losses to advance,…
6 months ago benzinga.com
12 Health Care Stocks Moving In Monday's Pre-Market Session
12 Health Care Stocks Moving In Monday's Pre-Market Session
6 months ago benzinga.com
Why Is Organon Stock Skyrocketing Monday?
Sun Pharma to acquire Organon in an all-cash deal valued at $11.75 billion. OGN shares rise on the acquisition news.
6 months ago benzinga.com
Why Organon Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Organon & Co (OGN) jumped 14.8% in pre-market trading as Sun Pharma agreed to acquire the company for $11.75 billion, $2 higher than current price.
6 months ago benzinga.com
Organon To Be Acquired By Sun Pharma In $11.75B Deal, OGN Stock Spikes Nearly 17% On Robinhood 24-Hour Market
Organon & Co. has agreed to be acquired by Sun Pharmaceutical Industries in an all-cash deal valued at $11.75 billion, offering shareholders a 103% premium and marking a major step in Sun Pharma's…
6 months ago benzinga.com
Nasdaq 100 Marks Fresh Records, Intel Jumps 23% On AI Chip Mania: Stock Market Today
Nasdaq 100 hit a fresh record as Intel surged 23% on a blowout quarter, while Charter Communications cratered and WTI sank 2% on Iran talks.
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session
6 months ago benzinga.com
Sensient Technologies, Chemed, AMD, Arm And Other Big Stocks Moving Higher On Friday
U.S. stocks mixed with Dow down 150 pts. Sensient Technologies Corp (NYSE:SXT) shares up 15.8% after beating earnings estimates. Other big gainers include Maxlinear Inc (NASDAQ:MXL), Intel Corp…
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Friday's Pre-Market Session
-
6 months ago benzinga.com
Reported Earlier: 'Sun Pharma, Grünenthal Are Said to Vie for US-Listed Organon' - Bloomberg
https://www.bloomberg.com/news/articles/2026-04-16/sun-pharma-grunenthal-are-said-to-vie-for-us-listed-organon
-
6 months ago benzinga.com
Organon Says VTAMA Creamwas Granted Strong, Evidence-Based Recommendation By AAD In 2026 Guidelines For Management And Treatment Of AD In Pediatric Patients, Published On April 7
The American Academy of Dermatology (AAD) provided a strong, evidence-based recommendation for the use of VTAMA cream, the only steroid-free topical treatment the AAD found to be supported by a high…
6 months ago benzinga.com
Dow Dips Over 250 Points: Investor Sentiment Declines, Greed Index Remains In 'Fear' Zone
An index measuring market sentiment based on fear and greed showed a slight increase in fear levels on Friday.
6 months ago benzinga.com
Nasdaq Moves Higher; US Inflation Rate Accelerates In March
U.S. stocks mixed, Nasdaq up 100 points. Inflation rate surges to 3.3%. Japan's Nikkei 225 and China's Shanghai Composite close higher.
6 months ago benzinga.com
Trump Throws A Lifeline To Palantir, Nasdaq 100 Targets 8th Green Day: What's Moving Markets Friday?
Tech stocks rise as the Nasdaq 100 targets an 8-day streak, even as inflation spikes and consumer sentiment hits a record low. Trump lifts Palantir, oil rebounds and AI chips surge on TSMC strength.
-
6 months ago benzinga.com
12 Health Care Stocks Moving In Friday's Intraday Session
12 Health Care Stocks Moving In Friday's Intraday Session